Participants will receive free state of the art body fat analysis using the bodpod technology, blood hba1c, lipid, and sugar (glucose) analysis, physical activity monitoring and dietary analysis.

Participants will receive free state of the art body fat analysis using the bodpod technology, blood hba1c, lipid, and sugar (glucose) analysis, physical activity monitoring and dietary analysis.

Oral tablet; starting dose at 10 mg for subjects with an egfr between 25 to < 60 ml/min/1.73m² at the screening visit; starting dose at 20 mg for subjects with an egfr ≥ 60 ml/min/1.73m² at the screening visit; dose could be up-titrated from month 1 onwards or down-titrated at any time during the study; once daily in the morning, until the trial was completed provided there were no safety.